DGAP-News: Formycon Reports First Quarter 2022 Financial Results and Announces Development Start of two New Biosimilar Candidates FYB208 and FYB209

DGAP-News: Formycon AG / Key word(s): Quarter Results
Formycon Reports First Quarter 2022 Financial Results and Announces Development Start of two New Biosimilar Candidates FYB208 and FYB209

21.06.2022 / 07:30
The issuer is solely...
Quelle: Börse Online RSS Feed